Daniel R. Passeri, CHIEF EXECUTIVE OFFICER at Cue Biopharma, Inc. (CUE), bought 30,000 shares at $1.03 ($31K) on 2024-12-16, disclosed to the SEC on 2024-12-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CUE | BUY | 2019-06-25 | $10K | — | Filing → |
| CUE | BUY | 2019-06-07 | $21K | — | Filing → |
| CUE | BUY | 2018-08-20 | $49K | — | Filing → |